Fundz

Icon O Vir Bio, Inc. reported raising $77 Million in an initial SEC Form D filing, from an offering of $77 Million

PRIVATEDec 14, 2020

Amount Raised

$77 Million

$77 Million sold, per SEC Form D (first sale Dec 14, 2020)

Round Type

Venture

San DiegoBiotechnology

Quick answer

IconOVir Bio raised $77 Million in a funding round, dated December 14, 2020. IconOVir Bio is based in San Diego, California, United States.

How much did IconOVir Bio raise?
IconOVir Bio raised $77 Million in a funding round on December 14, 2020.
What does IconOVir Bio do?
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer.
Where is IconOVir Bio based and how big is it?
IconOVir Bio is based in San Diego, California, United States. Fundz records about 15 employees.
Who are the decision-makers at IconOVir Bio?
Fundz holds 1 contact at IconOVir Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as IconOVir Bio that raised within 45 days of this round, from Fundz verified event records.

Who to call at IconOVir Bio, and when

A new round usually means IconOVir Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day IconOVir Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at IconOVir Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at IconOVir Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

IconOVir Bio

Location

4570 Executive Drive

San Diego, California, United States

About

IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment IconOVir Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts8 people are listed at IconOVir Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for IconOVir Bio's next move

See what Strategic adds

IconOVir Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.